‘Quest to Cure MSA in Honor of Rex Griswold’ drives in-depth genomic investigation of rare nerve disorderContinue reading
Author Archive: AZBio
Sports, Concussion Safety and “Barrow Brain Ball”
The effects of concussions (mild traumatic brain injury or mTBI) has been big news of late in the world of professional sports. But for many of us, the facts about the impacts of mTBI on younger athletes are less well known.Continue reading
Telecommunication and Technology Saving Lives
Telecommunications Connectivity and Technology Saving Lives!
Mark your calendar for October 30, 2013 at the Shrine Auditorium
(El-Zaribah Shrine) at 552 N. 40th Street in Phoenix
with locations in Flagstaff and Tucson and online anywhere.
Time: 11 am to 4 pm.
This is the annual event to learn how technology and telecommunications enable better access toOur fifth annual telehealth event presented by the Arizona Bio Association (AZBIO), Arizona, Telecommunications and Information Council (ATIC) and the Arizona Telemedicine Program (ATP) healthcare.
Keynotes:
Keynote from Randy Roberson, a leading master of disaster telehealth management. Keynote from
Dr. Richard Carmona, Surgeon General (2002-2006) and expert on future business models for
healthcare.
How to attend:
Register to join us live in Phoenix ($10 – includes lunch and beverages)
Remote access will be provided online at no charge. Two remote-attendance locations in Flagstaff and
Tucson are arranged as well, at no charge. More than enough free parking at the Shrine Auditorium.
Why you and your network should attend:
- Telehealth Technology Showcase
- Get close to the latest telehealth technologies available now and coming to market
- See which technologies save lives right here in Arizona
- Network with those creating state-of-the-art telehealth technology
- Meet national and international telehealth experts from right here in Arizona
Sponsor – Exhibit
Exhibitor space (30 max): $225 for 5-foot table (floor equivalent), 2 chairs, quarter-page ad, mention
in all collateral, 2 attendees.
Major sponsor (5 max): $750 for major exhibit space, podium acknowledgment, half-page ad, website
listing, mention in all collateral and signage, 5 attendees.
Premiere event sponsor (4 max):$1500 includes premier exhibit space, spokesperson brief remarks
from podium, multiple acknowledgement announcements, a full page ad in the program document,
website logo, featured mention in all collateral and signage, and up to 10 prepaid attendees.
For more information on sponsor and exhibit opportunities
Contact ATIC by phone at 602-254-5887 or by e-mail at atic@researchedge.com
Opportunity Alert – Mission3 is Hiring
Mission3 is looking for a Development Engineer to join their teamContinue reading
Celebration Stem Cell Centre Attains Internationally Recognized AABB Accreditation
GILBERT, AZ (August 26, 2013) – Celebration Stem Cell Centre (CSCC), a hybrid public and private umbilical cord blood bank, stem cell contract manufacturer, and stem cell research facility, announced that it has obtained AABB Accreditation, which demonstrates CSCC’s commitment to quality and assures that the highest quality of cellular therapy products are manufactured at CSCC.Continue reading
Myriad Decision Opens the Door for Increased Competition and New Opportunities
The U.S. Supreme Court recently held in Association for Molecular Pathology v. Myriad Genetics that isolated gene sequences are not patent eligible because they are naturally occurring nucleic acids. This ruling brings new opportunities as well as new challenges to the biotech industry of which investors, inventors, and researchers need to be aware.Continue reading
FDA Issues Final Guidance on Clinical Trial IRBs
On Tuesday, August 27th, the FDA finalized its Guidance for Institutional Review Boards, Clinical Investigators and Sponsors on Institutional Review Board Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an Investigational New Drug/Investigational Device Exemption is Needed. Continue reading
UA-Developed Apps Aid Arizona Cotton Farmers
By Gabrielle Fimbres for the College of Agriculture and Life Sciences, August 27, 2013
Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
- Attractive Addition to Amgen’s Leading Oncology Portfolio and Pipeline
- Kyprolis® (carfilzomib) for Injection is at Early Stages of Launch in Multiple Myeloma; Showing Strong Physician Support
- Acquisition Expected to Contribute to Growth and Value for Amgen Shareholders
- Amgen to Host Analyst/Investor Call Monday at 8:30 a.m. EDT (5:30 a.m. PDT)Continue reading
New tool enhances the search for genetic mutations
Written by: Richard Harth
Science Writer: Biodesign Institute richard.harth@asu.eduContinue reading